Form: SC 13G

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

July 10, 2024

Documents

 

EXHBIIT A

 

JOINT FILING AGREEMENT

 

The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of common stock, no par value, of Acasti Pharma Inc. dated as of July 10, 2024 is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

 

ADAR1 CAPITAL MANAGEMENT, LLC  
   
/s/ Daniel Schneeberger  
Manager of ADAR1 Capital Management, LLC  

 

ADAR1 CAPITAL MANAGEMENT GP, LLC  
   
/s/ Daniel Schneeberger  
Manager of ADAR1 Capital Management GP, LLC  

 

DANIEL SCHNEEBERGER  
   
/s/ Daniel Schneeberger  

 

1